|
HYLS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.891900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.136400E-02 |
| Normal-vs-Stage2 |
5.092200E-01 |
| Normal-vs-Stage3 |
9.689800E-01 |
| Normal-vs-Stage4 |
7.526200E-01 |
| Stage1-vs-Stage2 |
6.946600E-01 |
| Stage1-vs-Stage3 |
3.737600E-01 |
| Stage1-vs-Stage4 |
4.903200E-01 |
| Stage2-vs-Stage3 |
6.724200E-01 |
| Stage2-vs-Stage4 |
5.937200E-01 |
| Stage3-vs-Stage4 |
6.986000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.982340E-02 |
| Normal-vs-AfricanAmerican |
8.877600E-01 |
| Normal-vs-Asian |
2.155500E-02 |
| Caucasian-vs-AfricanAmerican |
6.554500E-02 |
| Caucasian-vs-Asian |
1.475790E-02 |
| AfricanAmerican-vs-Asian |
2.223000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.496800E-03 |
| Normal-vs-Female |
3.400600E-01 |
| Male-vs-Female |
1.535050E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.806800E-01 |
| Normal-vs-Extreme_Weight |
2.384900E-03 |
| Normal-vs-Obese |
3.727000E-01 |
| Normal-vs-Extreme_Obese |
4.633400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.952200E-02 |
| Normal_Weight-vs-Obese |
7.292800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.427600E-01 |
| Extreme_Weight-vs-Obese |
1.868420E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.263600E-01 |
| Obese-vs-Extreme_Obese |
6.957200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.491570E-01 |
| Normal-vs-Age(41-60Yrs) |
7.957800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.658100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.313760E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.396040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.231300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.719200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.215300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.593800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.615600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.226100E-02 |
| Normal-VS-Type2 PRCC |
2.312800E-01 |
| Normal-VS-KIRP CIMP |
1.109230E-01 |
| Normal-VS-Unclassified PRCC |
2.809200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.318400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.775900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.979800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.270100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.302200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.087800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.645600E-01 |
| Normal-vs-N1 |
2.257400E-01 |
| Normal-vs-N2 |
1.86053999999825E-05 |
| N0-vs-N1 |
5.830400E-02 |
| N0-vs-N2 |
4.44969999999767E-05 |
| N1-vs-N2 |
1.61789999997275E-06 |
|
|
